SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-22-000063
Filing Date
2022-05-09
Accepted
2022-05-09 08:02:59
Documents
75
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sesn-20220331.htm   iXBRL 10-Q 1109484
2 EX-10.1 sesn-ex101xzurichlicenseag.htm EX-10.1 118996
3 EX-31.1 sesn-03312022x10qex3111.htm EX-31.1 11872
4 EX-31.2 sesn-03312022x10qex3121.htm EX-31.2 11772
5 EX-32.1 sesn-03312022x10qex3211.htm EX-32.1 6359
6 EX-32.2 sesn-03312022x10qex3221.htm EX-32.2 6334
  Complete submission text file 0001485003-22-000063.txt   6007273

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220331.xsd EX-101.SCH 52493
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20220331_cal.xml EX-101.CAL 42044
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20220331_def.xml EX-101.DEF 242826
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220331_lab.xml EX-101.LAB 592909
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220331_pre.xml EX-101.PRE 382638
69 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220331_htm.xml XML 789593
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 22903313
SIC: 2834 Pharmaceutical Preparations